Jeeva et al. (30) documented a single occurrence of endophthalmitis (1/15,338) in the context of bilateral intravitreal anti-VEGF injections performed in an operating room, indicating no significant disparity in safety when compared to unilateral injections (30, 33–35). This evidence concerns the gene VEGFA and endophthalmitis.